These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24762312)

  • 41. Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.
    Castillo Ramirez JA; Urcuqui-Inchima S
    J Interferon Cytokine Res; 2015 Jun; 35(6):421-30. PubMed ID: 25629430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.
    Briggs CM; Smith KM; Piper A; Huitt E; Spears CJ; Quiles M; Ribeiro M; Thomas ME; Brown DT; Hernandez R
    J Virol; 2014 Jun; 88(12):6729-42. PubMed ID: 24696467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
    Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.
    Ramírez R; Falcón R; Izquierdo A; García A; Alvarez M; Pérez AB; Soto Y; Muné M; da Silva EM; Ortega O; Mohana-Borges R; Guzmán MG
    Virus Genes; 2014 Oct; 49(2):185-95. PubMed ID: 24854144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells.
    Beaumier CM; Jaiswal S; West KY; Friberg H; Mathew A; Rothman AL
    Viral Immunol; 2010 Oct; 23(5):477-85. PubMed ID: 20883162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice.
    Feng K; Zheng X; Wang R; Gao N; Fan D; Sheng Z; Zhou H; Chen H; An J
    Front Cell Infect Microbiol; 2020; 10():87. PubMed ID: 32257963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.
    Elong Ngono A; Chen HW; Tang WW; Joo Y; King K; Weiskopf D; Sidney J; Sette A; Shresta S
    EBioMedicine; 2016 Nov; 13():284-293. PubMed ID: 27746192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of dengue virus-specific polyfunctional T-cell responses with clinical disease severity in acute dengue infection.
    Wijeratne DT; Fernando S; Gomes L; Jeewandara C; Jayarathna G; Perera Y; Wickramanayake S; Wijewickrama A; Ogg GS; Malavige GN
    Immun Inflamm Dis; 2019 Dec; 7(4):276-285. PubMed ID: 31568656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement.
    Hughes HR; Crill WD; Chang GJ
    Virol J; 2012 Jun; 9():115. PubMed ID: 22709350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune response to dengue virus and prospects for a vaccine.
    Murphy BR; Whitehead SS
    Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8(+) T cells and antibody when expressed from modified vaccinia Ankara.
    Quinan BR; Flesch IE; Pinho TM; Coelho FM; Tscharke DC; da Fonseca FG
    Vaccine; 2014 May; 32(25):2972-9. PubMed ID: 24726244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.
    Borges MB; Marchevsky RS; Carvalho Pereira R; da Silva Mendes Y; Almeida Mendes LG; Diniz-Mendes L; Cruz MA; Tahmaoui O; Baudart S; Freire M; Homma A; Schneider-Ohrum K; Vaughn DW; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L
    PLoS Pathog; 2019 Apr; 15(4):e1007721. PubMed ID: 31009499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2.
    Stauft CB; Song Y; Gorbatsevych O; Pantoja P; Rodriguez IV; Futcher B; Sariol CA; Wimmer E
    Virology; 2019 Nov; 537():237-245. PubMed ID: 31539771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody.
    Tian Y; Chen W; Yang Y; Xu X; Zhang J; Wang J; Xiao L; Chen Z
    Appl Microbiol Biotechnol; 2013 Feb; 97(4):1553-60. PubMed ID: 23081772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
    Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
    Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
    Uno N; Ross TM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.
    Wan SW; Lu YT; Huang CH; Lin CF; Anderson R; Liu HS; Yeh TM; Yen YT; Wu-Hsieh BA; Lin YS
    PLoS One; 2014; 9(3):e92495. PubMed ID: 24658118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.
    Ahmed SF; Quadeer AA; Barton JP; McKay MR
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008676. PubMed ID: 32956362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.